|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print March 7, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00022.2002
Submitted on January 14, 2002
Accepted on March 4, 2002
1 Neurology, University of Minnesota, Minneapolis, MN, USA
2 Mayo Clinic Jacksonville, Jacksonville, FL, USA
3 McLaughlin Reseach Insitute, Great Falls, MT, USA
* To whom correspondence should be addressed. E-mail: iadec001{at}umn.edu.
The Aß peptide, derived from the amyloid precursor protein (APP), is involved in the pathogenesis of Alzheimer's dementia and impairs endothelium-dependent vasodilation in cerebral vessels. We investigated whether cerebrovascular autoregulation, i.e., the ability of the cerebral circulation to maintain flow in the face of changes in mean arterial pressure (MAP), is impaired in transgenic mice overexpressing APP and Aß. Neocortical cerebral blood flow (CBF) was monitored by laser-Doppler flowmetry in anesthetized APP+ and APP- mice. MAP was elevated by i.v. infusion of phenylephrine and reduced by controlled exanguination. In APP- mice autoregulation was preserved. However, in APP+ mice, autoregulation was markedly disrupted. The magnitude of the disruption was linearly related to brain Aß concentration. The failure of autoregulation was paralleled by impairment of the CBF response to endothelium-dependent vasodilators. Thus, Aß disrupts a critical homeostatic mechanism of the cerebral circulation and renders CBF highly dependent on MAP. The resulting alterations in cerebral perfusion may play a role in the brain dysfunction and periventricular white matter changes associated with Alzheimer's dementia.
This article has been cited by other articles:
![]() |
B. H. Han, M.-l. Zhou, F. Abousaleh, R. P. Brendza, H. H. Dietrich, J. Koenigsknecht-Talboo, J. R. Cirrito, E. Milner, D. M. Holtzman, and G. J. Zipfel Cerebrovascular Dysfunction in Amyloid Precursor Protein Transgenic Mice: Contribution of Soluble and Insoluble Amyloid-{beta} Peptide, Partial Restoration via {gamma}-Secretase Inhibition J. Neurosci., December 10, 2008; 28(50): 13542 - 13550. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Smith, M. Vijayappa, F. Lima, P. Delgado, L. Wendell, J. Rosand, and S. M. Greenberg Impaired visual evoked flow velocity response in cerebral amyloid angiopathy Neurology, October 28, 2008; 71(18): 1424 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nicolakakis, T. Aboulkassim, B. Ongali, C. Lecrux, P. Fernandes, P. Rosa-Neto, X.-K. Tong, and E. Hamel Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor {gamma} Agonist J. Neurosci., September 10, 2008; 28(37): 9287 - 9296. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein PNAS, January 29, 2008; 105(4): 1347 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hamel, N. Nicolakakis, T. Aboulkassim, B. Ongali, and X-K. Tong Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease Exp Physiol, January 1, 2008; 93(1): 116 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy Brain, September 1, 2007; 130(9): 2310 - 2319. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Girouard and C. Iadecola Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease J Appl Physiol, January 1, 2006; 100(1): 328 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease J. Neurosci., November 30, 2005; 25(48): 11165 - 11174. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Park, J. Anrather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. A. Carlson, and C. Iadecola NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid {beta} Peptide J. Neurosci., February 16, 2005; 25(7): 1769 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Krezowski, D. Knudson, C. Ebeling, R. Pitstick, R. K. Giri, D. Schenk, D. Westaway, L. Younkin, S. G. Younkin, K. H. Ashe, et al. Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression Hum. Mol. Genet., September 15, 2004; 13(18): 1989 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Suo, M. Wu, B. A. Citron, G. T. Wong, and B. W. Festoff Abnormality of G-Protein-Coupled Receptor Kinases at Prodromal and Early Stages of Alzheimer's Disease: An Association with Early {beta}-Amyloid Accumulation J. Neurosci., March 31, 2004; 24(13): 3444 - 3452. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Iadecola Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer's Dementia Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1951 - 1953. [Full Text] [PDF] |
||||
![]() |
A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2055 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mueggler, D. Baumann, M. Rausch, M. Staufenbiel, and M. Rudin Age-Dependent Impairment of Somatosensory Response in the Amyloid Precursor Protein 23 Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., September 10, 2003; 23(23): 8231 - 8236. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Iadecola and P. B. Gorelick Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia Stroke, February 1, 2003; 34(2): 335 - 337. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |